BREntuximab Vedotin in SEcond LIne Therapy BEfore Transplant

Clinical trial NCT04378647 · RECRUITING

Trial details

NCT number: NCT04378647
Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin Lymphoma, Adult

Start date: 2020-06-01
Primary completion: 2026-08-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.